About Cleerly
Cleerly is a comprehensive, AI-driven platform that quantifies and assesses coronary artery disease (CAD) to deliver clinically actionable insights through a web-based solution. The company's software leverages machine learning to analyze coronary computed tomography angiography (CCTA) scans, providing detailed measurements of atherosclerosis including plaque volume, composition, length, and location. Cleerly evaluates stenosis severity in both 2D (diameter and area) and 3D (lumen and vessel volume) formats, with an integrated workflow for determining the likely presence or absence of ischemia. The platform aims to reduce the need for additional testing while enhancing diagnostic confidence for healthcare providers. Cleerly's product suite includes Cleerly Plaque Analysis, Cleerly ISCHEMIA, and Cleerly COMPARE, serving healthcare providers, health systems, and payors. The company's technology has been validated through clinical trials including the prospective, multicenter CREDENCE trial, where Cleerly ISCHEMIA demonstrated higher diagnostic accuracy compared to FFRCT and stress testing when referenced against invasive fractional flow reserve (FFR) measurements. In the PACIFIC study post-hoc analysis, Cleerly ISCHEMIA was the only non-invasive ischemia test that was prognostic of future major adverse cardiac events (MACE). The platform provides comprehensive, accurate, and trackable insights to personalize treatment decisions and improve patient outcomes in cardiac care.
Clinical Focus
Medical conditions and clinical areas addressed by Cleerly.
Who It Serves
Milestones & Awards
Recent Milestones
New commercial insurance coverage announced. Category I CPT code approval for clinical billing.
Social & Media
Follow on
Latest Updates
The Recipe to a Healthy Heart: Your Guide to Preventing Heart Disease
1y ago
The Recipe to a Healthy Heart: Your Guide to Heart Disease Prevention
1y ago
The Recipe to a Healthy Heart: Your Guide to Preventing Heart Disease
1y ago
2023 in Review: Recognition, Growth, Continuous Innovation at Cleerly
2y ago
2023 in Review: Recognition, Growth, Continuous Innovation at Cleerly
2y ago
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.